Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Sibley Memorial Hospital selects Hitachi for their proton beam therapy system in Washington

Hitachi announced that Johns Hopkins Medicine has selected Hitachi to provide its proton beam therapy (PBT) system at Sibley Memorial Hospital located in Washington, D.C.

This collaboration, which includes a 10-year maintenance service, marks the first multi-room PBT application in the nation’s capital. This will be Hitachi’s fifth PBT system in North America.

The next-generation system "PROBEAT", which comes with IMPT (Intensity Modulated Proton Therapy) and cone-beam CT, will have improved spot scanning capability in all 3 gantry-type treatment rooms, along with a fixed irradiation room dedicated to cancer research.

Toshiaki Higashihara, President & COO of Hitachi, Ltd. stated that, "As one of the leaders in cancer research and treatment, the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center’s philosophy of being at the leading edge of cancer treatment through research and development is very similar to our Social Innovation concept which supports a healthy and secure society through innovative technologies, systems, solutions and services."

In December 2007, Hitachi was the first company in the U.S. to clear FDA Premarket Notification Special 510(k) for the "PROBEAT" system with its spot scanning irradiation technology. Hitachi has delivered the first hospital based spot scanning system in May 2008 and has treated over 1,500 patients to date.

The same spot scanning system has already been installed at Nagoya Proton Therapy Center and Hokkaido University in Japan. In fiscal year 2015 (ending March 2016), one of Hitachi’s new PBT site is planning to start treatment of patients.

Hitachi has shown great stability in the proton market through continued investment in research and development, track record for high clinical availability of over 98%, along with a commitment to a long term partnership with all of its clients.

Proton Beam Therapy (PBT) is an advanced type of cancer radiotherapy. Protons from a hydrogen atom are extracted and accelerated up to 70% the speed of light. Its energy is concentrated directly on the tumor while avoiding radiation dose to the surrounding healthy tissues.